Clinical Trials
2 trialsNCT03480776 2026-01-14
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
Canadian Cancer Trials Group
Phase 2 Active not recruiting
NCT02659384 2023-03-14
Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed